IP Verse

(1R, 2R)-3-(Dimenthyl Amino-1-Ethyl-2-Methyl-Propyl) Phenol For Treating Painful Inflammations

Patent No. EP3241550 (titled "(1R, 2R)-3-(Dimenthyl Amino-1-Ethyl-2-Methyl-Propyl) Phenol For Treating Painful Inflammations") was filed by Grnenthal on Nov 18, 2003. The application was issued on Jul 22, 2020.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (4)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
GENERICS UKApr 22, 2021ELKINGTON AND FIFE
TEVA PHARMACEUTICALSApr 21, 2021GREINER
HEXALApr 20, 2021KRAUS & LEDERER PARTGMBB
DR SCHONApr 16, 2021DR SCHON

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3241550

GRNENTHAL
Application Number
EP17020237A
Filing Date
Nov 18, 2003
Status
Revoked
Feb 23, 2024
Publication Date
Jul 22, 2020
External Links
Slate, Register , Google Patents